Skip to Content

Columbia committee to discuss emerging opioids, including nitazenes and 7-OH

Image of Nitazenes
DEA
Image of Nitazenes

COLUMBIA, Mo. (KMIZ)

Columbia’s Substance Use Prevention Advisory Commission is scheduled to discuss new opioid-related public health threats during its noon meeting Wednesday.

The agenda item was added after several people expressed interest in learning more about the substances and their potential harms, commission chair Molly Lindner said. The discussion is meant to educate commission members about substances such as nitazines, cychlorphine, kratom and 7-OH, said Columbia/Boone County Health Department spokesperson Austin Krohn.

A September fact sheet from Missouri Partners in Prevention covers those substances and tianeptine. It describes nitazenes and cychlorphine as synthetic opioids. Kratom comes from a Southeast Asian tree, and 7-OH is a compound found in kratom. Concentrated 7-OH products are different from products made from kratom leaf, the fact sheet says.

Missouri agencies warned in March that nitazenes had been found in counterfeit pills, powders, unregulated cannabis products and vape liquid. The Missouri Department of Health and Senior Services said nitazenes were implicated in 14 Missouri overdose deaths in 2024, more than triple the total recorded from 2019 through 2023.

The state also has used sewage testing to monitor for drugs in schools. Nitazenes were detected in samples from 26 of 37 participating schools during the 2025–26 school year, according to the Department of Public Safety. The department says those detections declined and eventually disappeared by the end of the school year.

The current program is expected to test sewage from 164 school districts during the 2026–27 school year, including for nitazenes, cychlorphine and 7-OH. Wastewater results do not identify an individual.

The fact sheet also discusses tianeptine, an antidepressant that is not approved for medical use in the United States and can have opioid-like effects.

In July, the Drug Enforcement Administration proposed placing tianeptine in Schedule I. The proposal has not taken effect. Schedule I substances are defined by the DEA as having a high potential for abuse, no currently accepted medical use in the United States and a lack of accepted safety for use under medical supervision.

The Food and Drug Administration says tianeptine is not approved for medical use and considers dietary supplements containing it adulterated under federal law.

The commission’s meeting is scheduled for noon at the Department of Public Health and Human Services Training Room, 1005 W. Worley St.

Article Topic Follows: Columbia

Jump to comments ↓

Ellyse Edwards

BE PART OF THE CONVERSATION

ABC 17 News is committed to providing a forum for civil and constructive conversation.

Please keep your comments respectful and relevant. You can review our Community Guidelines by clicking here.

If you would like to share a story idea, please submit it here.